S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
MarketBeat Week in Review – 1/23- 1/27
Lots of sound and fury on US debt, but not a crisis — yet
The Next Big Crisis Is Here (Ad)
Italy's premier visits Libya for talks on energy, migration
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
The Next Big Crisis Is Here (Ad)
Japan firm opens whale meat vending machines to push sales
Online system to seek asylum in US is quickly overwhelmed
NYSE:CHE

Chemed - CHE Stock Forecast, Price & News

$498.94
-2.62 (-0.52%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$492.71
$501.19
50-Day Range
$490.00
$524.10
52-Week Range
$430.16
$528.72
Volume
48,950 shs
Average Volume
61,045 shs
Market Capitalization
$7.42 billion
P/E Ratio
28.99
Dividend Yield
0.30%
Price Target
$545.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
9.2% Upside
$545.00 Price Target
Short Interest
Healthy
1.99% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
0.80mentions of Chemed in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$4.44 M Sold Last Quarter
Proj. Earnings Growth
8.77%
From $18.69 to $20.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.79 out of 5 stars

Medical Sector

39th out of 1,055 stocks

Home Health Care Services Industry

2nd out of 9 stocks


CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
PNTG vs. CHE: Which Stock Is the Better Value Option?
Chemed (CHE) Q3 Earnings Surpass Estimates, EPS View Up
Chemed Q3 2022 Earnings Preview
See More Headlines
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Company Calendar

Last Earnings
10/31/2022
Ex-Dividend for 12/5 Dividend
11/10/2022
Dividend Payable
12/05/2022
Today
1/28/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,137
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$545.00
High Stock Price Forecast
$545.00
Low Stock Price Forecast
$545.00
Forecasted Upside/Downside
+9.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$268.55 million
Pretax Margin
16.13%

Debt

Sales & Book Value

Annual Sales
$2.14 billion
Cash Flow
$23.23 per share
Book Value
$39.62 per share

Miscellaneous

Free Float
14,271,000
Market Cap
$7.42 billion
Optionable
Optionable
Beta
0.55

Social Links


Key Executives

  • Kevin J. McNamaraKevin J. McNamara
    President, Chief Executive Officer & Director
  • David Patrick WilliamsDavid Patrick Williams
    Chief Financial Officer & Executive Vice President
  • Spencer S. LeeSpencer S. Lee
    Executive Vice President
  • Nicholas M. Westfall
    Executive Vice President
  • Thomas C. Hutton
    Director & Vice President













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2023?

1 analysts have issued 12-month target prices for Chemed's shares. Their CHE share price forecasts range from $545.00 to $545.00. On average, they expect the company's share price to reach $545.00 in the next twelve months. This suggests a possible upside of 9.2% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2023?

Chemed's stock was trading at $510.43 at the beginning of the year. Since then, CHE stock has decreased by 2.3% and is now trading at $498.94.
View the best growth stocks for 2023 here
.

Are investors shorting Chemed?

Chemed saw a drop in short interest in January. As of January 15th, there was short interest totaling 287,400 shares, a drop of 15.7% from the December 31st total of 341,000 shares. Based on an average daily volume of 82,300 shares, the short-interest ratio is presently 3.5 days. Currently, 2.0% of the shares of the stock are short sold.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) posted its quarterly earnings results on Monday, October, 31st. The company reported $4.74 EPS for the quarter, beating the consensus estimate of $4.61 by $0.13. The company earned $526.47 million during the quarter, compared to the consensus estimate of $527.05 million. Chemed had a trailing twelve-month return on equity of 44.29% and a net margin of 12.31%. The company's quarterly revenue was down 2.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $5.06 earnings per share.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, November 4th. Investors of record on Monday, November 14th will be paid a dividend of $0.38 per share on Monday, December 5th. This represents a $1.52 annualized dividend and a yield of 0.30%. The ex-dividend date is Thursday, November 10th.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.30%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.48% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY 2022 earnings guidance on Monday, November, 7th. The company provided earnings per share (EPS) guidance of $19.60-$19.70 for the period, compared to the consensus earnings per share estimate of $19.49. The company issued revenue guidance of -.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by many different retail and institutional investors. Top institutional investors include Boston Trust Walden Corp (1.30%), Copeland Capital Management LLC (1.06%), Riverbridge Partners LLC (0.68%), Natixis Advisors L.P. (0.36%), Trinity Street Asset Management LLP (0.20%) and Fenimore Asset Management Inc. (0.18%). Insiders that own company stock include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends
.

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $498.94.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $7.42 billion and generates $2.14 billion in revenue each year. The company earns $268.55 million in net income (profit) each year or $17.21 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,137 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 1/28/2023 by MarketBeat.com Staff